Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Nano dot technology enters clinical trials.

× No keyword cloud information.

5 in total

1. Synthesis and anticancer activity of carbosilane metallodendrimers based on arene ruthenium(ii) complexes.

Authors: Marta Maroto-Díaz; Benelita T Elie; Pilar Gómez-Sal; Jorge Pérez-Serrano; Rafael Gómez; María Contel; F Javier de la Mata
Journal: Dalton Trans Date: 2016-04-28 Impact factor: 4.390

2. Encapsulation of 16-Hydroxycleroda-3,13-Dine-16,15-Olide in Mesoporous Silica Nanoparticles as a Natural Dipeptidyl Peptidase-4 Inhibitor Potentiated Hypoglycemia in Diabetic Mice.

Authors: Po-Kai Huang; Shi-Xiang Lin; May-Jywan Tsai; Max K Leong; Shian-Ren Lin; Ranjith Kumar Kankala; Chia-Hung Lee; Ching-Feng Weng
Journal: Nanomaterials (Basel) Date: 2017-05-12 Impact factor: 5.076

Review 3. Fluorescent Nanobiosensors for Sensing Glucose.

Authors: Longyi Chen; Eugene Hwang; Jin Zhang
Journal: Sensors (Basel) Date: 2018-05-05 Impact factor: 3.576

Review 4. Nanoparticle-Mediated Therapeutic Agent Delivery for Treating Metastatic Breast Cancer-Challenges and Opportunities.

Authors: Yunfei Li; Brock Humphries; Chengfeng Yang; Zhishan Wang
Journal: Nanomaterials (Basel) Date: 2018-05-24 Impact factor: 5.076

5. The autophagic inhibition oral squamous cell carcinoma cancer growth of 16-hydroxy-cleroda-3,14-dine-15,16-olide.

Authors: Ming-Fang Cheng; Shian-Ren Lin; Fong-Jen Tseng; Yi-Chao Huang; May-Jywan Tsai; Yaw-Syan Fu; Ching-Feng Weng
Journal: Oncotarget Date: 2017-07-04

5 in total